Table 2. Medication prescriptions in 149 patients with end-stage renal disease, stratified by renal replacement therapy.
| Hemo- dialysis (n = 82) |
Peritoneal dialysis (n = 31) |
Kidney transplantation (n = 36) |
|
|---|---|---|---|
| Vitamin K antagonists (%) | 12 (15%) | 0 (0%) | 4 (11%) |
| Vitamin D analogs (%) | 57 (70%) | 25 (81%) | 4 (11%) |
| Any phosphate binder (%) | 60 (73%) | 29 (94%) | 0 (0%) |
| • Exclusively non-calcium containing phosphate binders (%) | 36 (44%) | 17 (55%) | 0 (0%) |
| ○ Sevelamer monotherapy (%) | 20 (24%) | 6 (19%) | 0 (0%) |
| • Exclusively calcium containing phosphate binders (%) | 6 (7%) | 4 (13%) | 0 (0%) |
Data are presented as numbers (percentage). Vitamin K antagonists prescribed were acenocoumarol and phenprocoumon, and vitamin D analogs prescribed were alfacalcidol.